BME103:T130 Group 11

From OpenWetWare

(Difference between revisions)
Jump to: navigation, search
(Research and Development)
(Results)
Line 349: Line 349:
* '''Integrated Density''' = This is the amount of pixels in an image or a selection of an image. We got these data by subtracting the integrated density of the drop selection and the black background.   
* '''Integrated Density''' = This is the amount of pixels in an image or a selection of an image. We got these data by subtracting the integrated density of the drop selection and the black background.   
* '''DNA μg/mL''' = This was calculated by multiplying the Integrated density of the sample, with the background subtracted, by two and then dividing by the calf thymus integrated density.  
* '''DNA μg/mL''' = This was calculated by multiplying the Integrated density of the sample, with the background subtracted, by two and then dividing by the calf thymus integrated density.  
-
* '''Conclusion''' = Positive means that the sample contains a positive test result cancer gene; no signal means the the sample contains a negative test result for the cancer gene. The samples that resulted with no signal meant that it produced a concentration that was smaller than that of the negative control. The samples that contained a positive test result produced a higher concentration than the negative control. From the data obtained, it appears that Patient 2 yielded a high level of DNA μg/mL, which resulted in a positive result for cancer in the first and second reps. In conclusion, Patient 2 most likely contains the cancer gene and Patient 1 does not based on the acquired results.         
+
* '''Conclusion''' = Positive means that the sample contains a positive test result cancer gene; no signal means the sample contains a negative test result for the cancer gene. The samples that resulted with no signal meant that it produced a concentration that was smaller than that of the negative control. The samples that contained a positive test result produced a higher concentration than the negative control. From the data obtained, it appears that Patient 2 yielded a high level of DNA μg/mL, which resulted in a positive result for cancer in the first and second reps. In conclusion, Patient 2 most likely contains the cancer gene and Patient 1 does not based on the acquired results.         

Revision as of 19:02, 15 November 2012

BME 103 Fall 2012 Home
People
Lab Write-Up 1
Lab Write-Up 2
Lab Write-Up 3
Course Logistics For Instructors
Photos
Wiki Editing Help
Image:BME494_Asu_logo.png

Contents

OUR TEAM

Name: Timothy PetersonRole:Research and Development Scientist
Name: Timothy Peterson
Role:Research and Development Scientist
Name: Sharon GooiRole: Experimental Protocol Planner
Name: Sharon Gooi
Role: Experimental Protocol Planner
Name: Derek BiahRole: Data Analyzer
Name: Derek Biah
Role: Data Analyzer
Name: Hunter Workman ImageJ Software Processor
Name: Hunter Workman
ImageJ Software Processor
Name: Steven CasaceliPCR Operator
Name: Steven Casaceli
PCR Operator
Name: Kory ChisholmFlexible Roles
Name: Kory Chisholm
Flexible Roles

LAB 1 WRITE-UP

Initial Machine Testing

The Original Design
Image:PCR.png

The PCR machine heats up the DNA so that enzymes can "unzip" the two strands of DNA. This process happens in cycles so that the DNA will seperate and duplicate a multitude of times. A certain amount of primer is used to duplicate the DNA specific to the amount of original DNA. By amplifying the amount of DNA, a proper diagnosis of a certain gene can be made.


Experimenting With the Connections

When we unplugged the LCD screen from the circuit board, the machine's screen shut off.

When we unplugged the white wire that connects the circuit board to tube PCR block, the machine stopped reading the temperature.

Test Run

We first tested the PCR machine on the 18th of October, 2012. We initially ran our sample testing on the 1st of November, 2012 on PCR machine 12. The LCD screen readings matched the reading on the computer PCR program, and the machine worked well and efficiently.




Protocols

Polymerase Chain Reaction (PCR)


The Polymerase Chain Reaction (PCR) is a process that depends on a DNA Polymerase enzyme's ability to synthesize a strand that is complementary to a targeted fragment of DNA in a test tube mixture of all four DNA bases, which are adenine, cytosine, guanine and thymine. Besides that, the test tube mixture also must have two fragments of DNA of about 20 base pairs that are called primers. These primers should have sequences complementary to adjacent areas of each side of the targeted DNA segment. Since these two primers should match exactly with only the targeted DNA sequence, only this area would be defined and copied.


For the process of PCR, there are different stages, and they are collectively called the heating-cooling cycle.


First of all, the sample to be tested would be added to the GoTAQ PCR master mix. Secondly, the mixture would be heated to separate the sides of the double-stranded DNA. Thirdly, the mixture would be cooled to an optimum temperature for the primers to find and bind to whichever side of the separated DNA strands that they are complementary to. Lastly, the temperature is then raised slightly to reach an optimum temperature for the polymerase, which is included in the test tube mixture, to extend the primers so that new complementary strands are generated. At the end of the first cycle, there will be two copies of the targeted DNA segment. The cycle is repeated multiple times to generate more and more copies of the targeted DNA segments. With the advent of technology in biological sciences and engineering, the entire process can be automated after all the correct components are added into a tube by using a thermocycler or a PCR machine such as the OpenPCR machine.



The PCR master mix that was obtained from Promega consists of several different substances. These include nuclease-free water, deoxynucleotide triphosphates (dNTPs), magnesium chloride, and reaction buffers at optimal concentrations for any amplification of DNA. The reaction buffers had a pH of 8.5, and were made of 400μm deoxyadenosine triphosphate (dATP), 400μm deoxyguanosine triphosphate (dGTP), 400μm deoxycytidine triphosphate (dCTP), 400μm deoxythymidine triphosphate (dTTP) as well as 3mM of magnesium chloride.


After taking image documents of all the samples on the fluorimeter, the ImageJ processor split the color channels of each image and measured the amount of pixels of the drop selection in the green image. The amount of pixels that were measured was then subtracted from the same background of the same area of selection. This subtraction gave the integrated density of each drop sample. The integrated density was used in the formula to find the DNA concentration in each drop.

This table below lists all of the reagents used as well as the volume used during this process.


Reagent Volume
Template DNA (20ng) 0.2 µL
10 µM forward primer 1.0 µL
10 µM reverse primer 1.0 µL
GoTaq master mix 50.0 µL
dH2O 47.8 µL
Total Volume 100.0 µL



During Week 2, there were eight samples that PCR was run on. These samples consisted of a positive control, a negative control, and three samples from Patient 1 and three samples from Patient 2. Below are the details concerning Patient 1 and Patient 2.


Patient 1

ID #: 11640

Gender: Female

Age: 54 years old


Patient 2

ID #: 29292

Gender: Male

Age: 63 years old



Fluorimeter


The eight samples from the Polymerase Chain Reaction experiment were used in this experiment. In addition to that, eight Eppendrof tubes filled with 400ml of buffer to maximize fluorescence, a Eppendorf tube filled with DNA (calf thymus standard at 2 micrograms/ml; the tube was marked with a red dot on the cover), water in a scintillation vial, an Eppendorf tube filled with SYBR GREEN 1 (marked with a blue dot on the cover), several glass slides, a fluorimeter, a black box, a smartphone stand, a smartphone, a marker pen and several pipettes, a pipette with a blue strip, a pipette with a red strip, a pipette with a black strip and a pipette with a blank piece of paper taped to it, as well as a cup were used.


The eight Eppendrof tubes were labeled using the marker pen according to the eight samples from the Polymerase Chain Reaction experiment; they were labeled +, -, 1a, 1b, 1c, 2a, 2b and 2c. Similarly, for each Eppendorf tube (ten altogether), a pipette for each tube was given a corresponding label. Using the corresponding pipettes, the eight samples from the Polymerase Chain Reaction experiment were transferred from their PCR tubes to their corresponding Eppendrof tubes. The pipettes were all kept carefully separate from each other.


The fluorimeter was set up according to the image shown.


A complete setup of the Fluorimeter


The pipette with the blue strip was used to put two large drops of SYBR GREEN I on the first two centered drops on the glass slide in the fluorimeter.(Warning: please do not dispose of any of the pipettes used until the entire process is complete!) Once that was done, The corresponding pipette for the positive control was used to add two drops of the sample of the positive control to the two drops of the SYBR GREEN I that was already on the glass slide. The light in the fluorimeter was aligned to ensure that it was going through the drop. The fluorimeter was covered with the black file box and the smartphone operator was allowed to take as many pictures as needed. After the pictures were taken, the pipette with the black strip was used to dispose of the drop on the glass slide into the cup. The slide was then pushed forward so that the light would be in the general direction of the next two centered holes on the glass slide.


The above process was then repeated using the next samples available, which were the negative control sample, sample 1a, 1b, 1c, 2a, 2b and 2c. Once the first five samples were done, shifting the glass slide down two holes after every sample, that glass slide was disposed off, and a new glass slide was used.


After these eight samples were run, two drops of SYBR GREEN I were put on the appropriate two centered drops before two drops of the Calf Thymus DNA from the Eppendrof tube with the red dot on top were added using the pipette with the red strip, and the above procedure was repeated. Lastly, after the slide was moved two holes down and two drops of SYBR GREEN I was added to the slide, the pipette with a blank piece of paper taped to it was used to add two drops of water from the scintillation vial on the slides, with the above procedure also being repeated on it. After all of this was done, the slides, pipettes, and all of the tubes containing the samples were disposed of in the correct waste containers.

Flourimeter Measurements

Tubes


Description Eppendorf Tube Label Pipette Label
Positive Control + +
Negative Control - -
Patient 1 Sample 1 1a 1a
Patient 1 Sample 2 1b 1b
Patient 1 Sample 3 1c 1c
Patient 2 Sample 1 2a 2a
Patient 2 Sample 2 2b 2b
Patient 2 Sample 3 2c 2c


DNA Measurement Operator: Smartphone


Image Number 2 Drops SYBRGr 2 Drops Comments
1A Patient 1 Sample 1 Darker blue tone with dark vertical streaks
1B Patient 1 Sample 2 Lighter Blue tone with very thin, vertical, fluorescent streaks
1C Patient 1 Sample 3 Lighter Blue tone with very fine, hazy fluorescent streaks
2A Patient 2 Sample 1 Light blue tone with thick,vertical, hazy, fluorescent streaks
2B Patient 2 Sample 2 Darker blue tone of drop with a variation of thick and fine, vertical, fluorescent streaks
2C Patient 2 Sample 3 Darker toned drop with very fine, wispy, fluorescent streaks
Positive Control (+) Positive Control Lighter blue drop with green round shape blobs displaced throughout
Negative Control (-) Negative control Lighter Blue drop with light, vertical streaks. No apparent fluorescence.
Water (H2O) Water Dark blue drop with no fluorescent streaks.
Calf Thymus Calf Thymus Dark blue drop with hazy, green, abstract round shapes distributed around the blob.


ImageJ Software Processor


Sample or Background ID Area and x, y, w, h, info Mean Pixel Value INTDEN RAWINTDEN INTDEN (IF DIFFERENT)
1a 69668 5.134 357674 same
1a background 69668 4.814 335409 same
1b 82952 14.383 1193134 same
1b background 82952 4.188 347364 same
1c 77078 29.946 2308181 same
1c background 77078 3.655 281721 same
2a 61076 78.280 4781047 same
2a background 61076 3.888 237445 same
2b 52524 50.560 2655589 same
2b background 52524 3.657 192067 same
2c 72068 21.003 1513624 same
2c background 72068 3.894 280632 same
+ Control 72476 97.093 7036889 same
+ Control background 72476 4.269 309387 same
- Control 48856 51.595 2520721 same
- Control background 48856 3.646 178142 same
Calf Thymus Standard 64720 76.988 4982678 same
Calf Thymus Standard background 64720 4.561 295190 same


Data Analyzer


Description INTDEN with background subtracted DNA Concentration, micrograms/ml
WATER BLANK 0
DNA CALF THYMUS, 2 microg/ml 4687488 2
PCR: Negative Control 2342579 0.999502932
PCR: Positive Control 6727502 2.870408202
PCR: Patient 1 ID 11640, rep 1 22265 0.009499758
PCR: Patient 1 ID 11640, rep 2 845770 0.36086279
PCR: Patient 1 ID 11640, rep 3 2026460 0.864625147
PCR: Patient 2 ID 29292, rep 1 4543602 1.938608483
PCR: Patient 2 ID 29292, rep 2 2463522 1.051105411
PCR: Patient 2 ID 29292, rep 3 1232992 0.526077933





Research and Development

Specific Cancer Marker Detection - The Underlying Technology

PCR helps to detect certain types of genes. In this case it is used to find out a specific type of cancer. In the process of detecting the cancer, primers are made to compliment a DNA strand that has the cancer gene in it. If a subject has the cancer in their DNA, the primers will bind to strand, whereas a subject without the cancer would not have a primer attach to their DNA strand.

The r1787996 SNP is linked to the cancer sequence. The codon ATC is the sequence for cancer where the ATT means there is no cancer. In PCR, the ATC cancer sequence is detected because the primers will only attach to the DNA strands that have the ATC sequence. The ATT, non-cancer, strands will not bind with the primers. Only the combined primer DNA strand will be detected thus alerting for cancer.



Bayes' Theorem

P(A|X) = \frac{P(X|A) P(A)}{P(X|A) P(A) + P(X|-A) P(-A)}


This rule can be used to determine the association between the probability of testing for cancer and whether or not the patient actually has cancer




Results

Sample Integrated Density DNA μg/mL Conclusion
PCR: Negative Control 2342579 0.999502932 -
PCR: Positive Control 6727502 2.870408202 +
PCR: Patient 1 ID 11640, rep 1 22265 0.009499758 -
PCR: Patient 1 ID 11640, rep 2 845770 0.36086279 -
PCR: Patient 1 ID 11640, rep 3 2026460 0.864625147 -
PCR: Patient 2 ID 29292, rep 1 4543602 1.938608483 +
PCR: Patient 2 ID 29292, rep 2 2463522 1.051105411 +
PCR: Patient 2 ID 29292, rep 3 1232992 0.526077933 -


KEY

  • Sample = The sample is a portion the DNA that was extracted from each patient.
  • Integrated Density = This is the amount of pixels in an image or a selection of an image. We got these data by subtracting the integrated density of the drop selection and the black background.
  • DNA μg/mL = This was calculated by multiplying the Integrated density of the sample, with the background subtracted, by two and then dividing by the calf thymus integrated density.
  • Conclusion = Positive means that the sample contains a positive test result cancer gene; no signal means the sample contains a negative test result for the cancer gene. The samples that resulted with no signal meant that it produced a concentration that was smaller than that of the negative control. The samples that contained a positive test result produced a higher concentration than the negative control. From the data obtained, it appears that Patient 2 yielded a high level of DNA μg/mL, which resulted in a positive result for cancer in the first and second reps. In conclusion, Patient 2 most likely contains the cancer gene and Patient 1 does not based on the acquired results.


Personal tools